17:03 EST aTyr Pharma files $300M mixed securities shelf
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on LIFE:
- aTyr Pharma reports Q3 EPS (20c), consensus (23c)
- aTyr Pharma to Present at November Investor Conferences
- aTyr Pharma announces dosing of first patient in Phase 2 EFZO-CONNECT study
- aTyr Pharma presents efzofitimod data
- aTyr Pharma Presents Efzofitimod Data Demonstrating Statistically Significant Improvements in Time to Relapse, FVC and Patient Reported Outcomes